预测covid-19住院患者临床恶化风险的模型开发与多中心外部验证研究
本研究为回顾性队列研究,用美国1家医院2015-21年数据训练线性模型集成,预测covid-19住院患者入院5天内复合结局(院内死亡或机械通气、加热高流量鼻导管、静脉血管升压药任一)。模型从2686个变量中筛选9个临床与个人特征变量。在13家医疗中心9291例covid-19相关住院中验证,1510例(16.3%)发生主要结局;内部验证AUROC 0.80(95%CI 0.77-0.84),预期校准误差0.01(95%CI 0.00-0.02),12家外部中心AUROC范围0.77-0.84。用模型分流低风险患者早期出院可能每例节省最多7.8个床位日。
要点
- 模型基于9个临床与个人特征变量,从2686个电子健康记录变量中筛选,预测入院5天内院内死亡或机械通气、加热高流量鼻导管、静脉血管升压药任一复合结局。
- 内部验证AUROC 0.80(95%CI 0.77-0.84),预期校准误差0.01(95%CI 0.00-0.02)。
- 12家外部医疗中心验证AUROC范围0.77-0.84,性别、年龄、种族、族裔亚组AUROC范围0.78-0.84,各季度AUROC范围0.73-0.83。
- 13家医疗中心9291例covid-19相关住院中1510例(16.3%)发生主要结局。
- 用模型分流低风险患者早期出院可能每例节省最多7.8个床位日。
适用人群与场景
- 美国1家医院2015-21年收治的成人(≥18岁)呼吸窘迫或covid-19住院患者,用于模型训练与内部验证。
- 美国12家其他医疗中心2020-21年收治的covid-19住院成人(≥18岁),用于外部验证。
研究设计与关键结果
- 研究类型为回顾性队列研究;开发队列来自美国1家医院2015-21年,外部验证在12家美国医疗中心2020-21年进行;共33119例成人(≥18岁)因呼吸窘迫或covid-19住院。
- 模型为线性模型集成,基于从2686个电子健康记录变量中选出的9个临床与个人特征变量,预测入院前5天内复合结局:院内死亡或机械通气、加热高流量鼻导管、静脉血管升压药任一治疗。
- 13家医疗中心共9291例covid-19相关住院用于模型验证,其中1510例(16.3%)发生主要结局。
- 内部验证AUROC 0.80(95%CI 0.77-0.84),预期校准误差0.01(95%CI 0.00-0.02)。
- 12家外部医疗中心验证AUROC范围0.77-0.84;性别、年龄、种族、族裔亚组AUROC范围0.78-0.84;各季度AUROC范围0.73-0.83。
- 用模型分流低风险患者早期出院可能每例节省最多7.8个床位日。
证据类型、等级与局限
- 证据类型:回顾性队列研究(模型开发与多中心外部验证)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该模型在多个医疗中心、患者亚组和时间段表现良好,有潜力作为优化医疗资源的工具。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To create and validate a simple and transferable machine learning model from electronic health record data to accurately predict clinical deterioration in patients with covid-19 across institutions, through use of a novel paradigm for model development and code sharing.
DESIGN: Retrospective cohort study.
SETTING: One US hospital during 2015-21 was used for model training and internal validation. External validation was conducted on patients admitted to hospital with covid-19 at 12 other US medical centers during 2020-21.
PARTICIPANTS: 33 119 adults (≥18 years) admitted to hospital with respiratory distress or covid-19.
MAIN OUTCOME MEASURES: An ensemble of linear models was trained on the development cohort to predict a composite outcome of clinical deterioration within the first five days of hospital admission, defined as in-hospital mortality or any of three treatments indicating severe illness: mechanical ventilation, heated high flow nasal cannula, or intravenous vasopressors. The model was based on nine clinical and personal characteristic variables selected from 2686 variables available in the electronic health record. Internal and external validation performance was measured using the area under the receiver operating characteristic curve (AUROC) and the expected calibration error-the difference between predicted risk and actual risk. Potential bed day savings were estimated by calculating how many bed days hospitals could save per patient if low risk patients identified by the model were discharged early.
RESULTS: 9291 covid-19 related hospital admissions at 13 medical centers were used for model validation, of which 1510 (16.3%) were related to the primary outcome. When the model was applied to the internal validation cohort, it achieved an AUROC of 0.80 (95% confidence interval 0.77 to 0.84) and an expected calibration error of 0.01 (95% confidence interval 0.00 to 0.02). Performance was consistent when validated in the 12 external medical centers (AUROC range 0.77-0.84), across subgroups of sex, age, race, and ethnicity (AUROC range 0.78-0.84), and across quarters (AUROC range 0.73-0.83). Using the model to triage low risk patients could potentially save up to 7.8 bed days per patient resulting from early discharge.
CONCLUSION: A model to predict clinical deterioration was developed rapidly in response to the covid-19 pandemic at a single hospital, was applied externally without the sharing of data, and performed well across multiple medical centers, patient subgroups, and time periods, showing its potential as a tool for use in optimizing healthcare resources.
参考来源
- Kamran F, Tang S, Otles E, et al. Early identification of patients admitted to hospital for covid-19 at risk of clinical deterioration: model development and multisite external validation study. BMJ. 2022. PMID: 35177406. doi:10.1136/bmj-2021-068576
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。